An AI tool appeared superior to two FDA-approved biomarkers for predicting how people with cancer will respond to immune checkpoint inhibitors.SCORPIO — a machine learning system developed by ...
Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback